Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mustajoki

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Journal of Internal Medicine|September 25, 1998
A nurse-managed weight reduction programme for obstructive sleep apnoea syndromeJ Lojander, P Mustajoki, S Rönkä, et al.
Journal of Internal Medicine|April 1, 1992
Frequency of low erythrocyte porphobilinogen deaminase activity in FinlandP Mustajoki, R Kauppinen, L Lannfelt, et al.
Genome Research|January 10, 1998
Steady-state transcript levels of the porphobilinogen deaminase gene in patients with acute intermittent porphyriaS Mustajoki, R Kauppinen, P Mustajoki, et al.
Human Molecular Genetics|February 1, 1995
Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase geneR Kauppinen, S Mustajoki, H Pihlaja, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy menP Mustajoki, S Mustajoki, A Rautio, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 27, 2001
Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre studyS Madsbad, B Kilhovd, I Lager, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1984
[Diagnosis and localization of pheochromocytoma]P Mustajoki, R Pelkonen, U M Pomoell, et al.
Nordisk Medicin|January 1, 1985
[Diagnosis and localization of pheochromocytoma]P Mustajoki, R Pelkonen, U M Pomoell, et al.
The Journal of Clinical Investigation|August 1, 1985
Acute intermittent porphyria: characterization of a novel mutation in the structural gene for porphobilinogen deaminase. Demonstration of noncatalytic enzyme intermediates stabilized by bound substrateR J Desnick, L T Ostasiewicz, P A Tishler, et al.
Trials|November 30, 2021
Prevention of leg cramps by using compression stockings or magnesium supplements in the 50-84 age group: study protocol for a randomised controlled trialJenni Joensuu, Pertti P Mustajoki, Pekka K Mustonen, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Journal of Internal Medicine|September 25, 1998
A nurse-managed weight reduction programme for obstructive sleep apnoea syndromeJ Lojander, P Mustajoki, S Rönkä, et al.
Journal of Internal Medicine|April 1, 1992
Frequency of low erythrocyte porphobilinogen deaminase activity in FinlandP Mustajoki, R Kauppinen, L Lannfelt, et al.
Genome Research|January 10, 1998
Steady-state transcript levels of the porphobilinogen deaminase gene in patients with acute intermittent porphyriaS Mustajoki, R Kauppinen, P Mustajoki, et al.
Human Molecular Genetics|February 1, 1995
Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase geneR Kauppinen, S Mustajoki, H Pihlaja, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy menP Mustajoki, S Mustajoki, A Rautio, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 27, 2001
Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre studyS Madsbad, B Kilhovd, I Lager, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1984
[Diagnosis and localization of pheochromocytoma]P Mustajoki, R Pelkonen, U M Pomoell, et al.
Nordisk Medicin|January 1, 1985
[Diagnosis and localization of pheochromocytoma]P Mustajoki, R Pelkonen, U M Pomoell, et al.
The Journal of Clinical Investigation|August 1, 1985
Acute intermittent porphyria: characterization of a novel mutation in the structural gene for porphobilinogen deaminase. Demonstration of noncatalytic enzyme intermediates stabilized by bound substrateR J Desnick, L T Ostasiewicz, P A Tishler, et al.
Trials|November 30, 2021
Prevention of leg cramps by using compression stockings or magnesium supplements in the 50-84 age group: study protocol for a randomised controlled trialJenni Joensuu, Pertti P Mustajoki, Pekka K Mustonen, et al.
Pageof 11